Upload
dangthuan
View
216
Download
0
Embed Size (px)
Citation preview
Role of Surgery in localised prostate cancer
Lee Lui ShiongDepartment of Urology, SGH
Director Urologic Oncology and Robotic [email protected]
Background
• 1947 – Milin retropubic prostatectomy
• 1982 – Walsh – nerve sparing RP
• 2000 – Montsouris team – lap RP
J Urol. 1982 Sep. 128(3):492-7J Urol. 2000; 163: 1643-9.
Modality
• Open
– Retropubic
– Perineal ( limited access to lymph nodes)
• Laparoscopic
• Robotic Assisted
Indication for surgery
• Organ confined disease- monotherapy
• High risk disease – as part of multimodality
• Radiorecurrent disease
• Cytoreductive prostatectomy - controversial
• PSA <50
• cT1-2
• Negative bone scan
• Age <75
• Life expectancy >10 years
• N=695 (recruitment complete)
• Mean PSA 13
• Only 12 % T1c disease
• watchful waiting ≠ active surveillance
• Progression – clinical progression , not PSA
• Benefit for radical surgery in prostate cancer in the pre-PSA era
• Proportion would be considered high risk/ locally advanced by current definition
• Under-powered
• Most subjects died in <10 years – “healthy”
• 20% did not receive allocated treatment option
• Take Home (PIVOT)
• Co-morbidities, life expectancy <10 years – don’t operate
Value of surgery (treatment)
• Surgery provides cancer specific survival and metastatic free survival
– intermediate to high risk disease ( Bill Axelson)
– low grade/ risk disease, poor ECOG -> marginal
• (active surveillance)
Additional benefit of surgery 1st line
• Relieve obstruction more expediently
• Treatment duration shorter - ? SBRT
• PSA – exquisitely sensitive
• Definite staging – stratify need for adjuvant therapy
Predictive models
• Partin tables – features at RP
• MSK nomogram – pre and post RP
• Briganti nomogram – nodal involvment pre-RP
Surgical quality indices
• Trifecta– Cancer control
– Continence
– Sexual
• Pentafecta– Trifecta +
– No complications
– Negative surgical marginsEur Urol 2011, 59:702-707
• Prostate Cancer Outcomes Study
• Diagnosed 1994-1995
• Age 55-74 yrs
• Surgery (n=1164), RT (n= 491)
• Surgery
• Urinary incontinence and ED more prevalent 2-5 years
• 15 years no difference
• RT
• Bowel symptoms more prevalent 2-5 years
• 15 years -> no difference
Penile rehabilitation
• Potent ( IIEF >16/25)
• Nerve sparing
• Early PDE5i after IDC removed
• 75-90% spontaneous potency with/without aids– Less than 65 yo
– Potent
– Bilateral nerve sparing
– Healthy ( DM, smoking)
Radiorecurrent disease
• PSA recurrence• Is it localised or systemic disease?
• Pheonix definition “2+ nadir”
• What defines an ideal nadir?• Should we waiting for 2 + to occur?
• Effect of ADT confounds assessment– Tail end of ADT– PSA Rebound
Take Home
• Surgery has a defined role in organ confined disease
• Survival benefit is best seen in the intermediate to high risk disease
• Defined quality indices for surgery
• Side effects include urinary and sexual dysfunction
• Salvage prostatectomy -> increased morbidity